Monitoring
Patients with TR should be followed up at regular intervals of 6 to 12 months. Evaluation should include clinical assessment with ECG and echocardiogram, and may be spaced out further in the absence of any new symptoms over several years.[5]
Use of this content is subject to our disclaimer